Clinical Trial Update: TVEC and Preop Radiation for Sarcoma (4 ml Dose) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating intralesional talimogene laherparepvec (T-VEC) with preoperative radiation for soft tissue sarcoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• T-VEC (talimogene laherparepvec)

Snippet

Sponsor: University of Iowa | Conditions: Soft Tissue Sarcoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-06-17